Consequences of loss of progesterone receptor expression in development of invasive endometrial cancer

Clinical Cancer Research

Volumn 9, Issue 11, 2003, Pages 4190-4199

  Hanekamp, Eline E ^a   Gielen, Susanne C J P ^a   Smid Koopman, Ellen ^a   Kühne, Liesbeth C M ^a   De Ruiter, Petra E ^a   Chadha Ajwani, Savi ^a   Brinkmann, Albert O ^a   Grootegoed, J Anton ^a   Burger, Curt W ^a   Huikeshoven, Frans J ^a   Blok, Leen J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; FIBRONECTIN; GESTAGEN; HERMES ANTIGEN; MEDROXYPROGESTERONE ACETATE; PROGESTERONE; PROGESTERONE RECEPTOR; TENASCIN; VERSICAN;

ACANTHAMOEBA; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CONTROLLED STUDY; DNA MICROARRAY; ENDOMETRIUM CANCER; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; METASTASIS; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; ANTIGENS, CD44; CELL LINE, TUMOR; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LECTINS, C-TYPE; MEDROXYPROGESTERONE 17-ACETATE; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROTEOCHONDROITIN SULFATES; RECEPTORS, PROGESTERONE; TENASCIN; VERSICANS;

EID: 0141455131     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Southcott, B. M. Carcinoma of the endometrium. Drugs, 61: 1395-1405, 2001.
2. Saegusa, M., and Okayasu, I. Progesterone therapy for endometrial carcinoma reduces cell proliferation but does not alter apoptosis. Cancer (Phila.), 83: 111-121, 1998.
3. Koopman, E., Blok, L. J., Brinkmann, A. O., Helmerhorst, T. J., and Huikeshoven, F. J. Differential gene expression in progesterone-sensitive and progesterone-insensitive endometrial carcinoma cells. Eur. J. Obstet. Gynecol. Reprod. Biol., 82: 135-138, 1999.
4. Kastner, P., Krust, A., Turcotte, B., Stropp, U., Tora, L., Gronemeyer, H., and Chambon, P. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J., 9: 1603-1614, 1990.
5. Vegeto, E., Shahbaz, M. M., Wen, D. X., Goldman, M. E., O'Malley, B. W., and McDonnell, D. P. Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Mol. Endocrinol., 7: 1244-1255, 1993.
6. Giangrande, P. H., Kimbrel, E. A., Edwards, D. P., and McDonnell, D. P. The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding. Mol. Cell. Biol., 20: 3102-3115, 2000.
7. Richer, J. K., Jacobsen, B. M., Manning, N. G., Abel, M. G., Wolf, D. M., and Horwitz, K. B. Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J. Biol. Chem., 277: 5209-5218, 2002.
8. Smid-Koopman, E., Blok, L. J., Kuhne, E. C. M., Burger, C. W., Helmerhorst, T. J. M. Brinkmann, A. O., Huikeshoven, F. J. Distinct functional differences of human progesterone receptors A and B on gene expression and growth regulation in two endomtrial carcinoma cell lines. J. Society Gyn. Investig., 2003.
9. Giangrande, P. H., Pollio, G., and McDonnell, D. P. Mapping and characterization of the functional domains responsible for the differential activity of the A and B isoforms of the human progesterone receptor. J. Biol. Chem., 272: 32889-32900, 1997.
10. Lim, C. S., Baumann, C. T., Htun, H., Xian, W., Irie, M., Smith, C. L., and Hager, G. L. Differential localization and activity of the A-and B-forms of the human progesterone receptor using green fluorescent protein chimeras. Mol. Endocrinol., 13: 366-375, 1999.
11. Moutsatsou, P., and Sekeris, C. E. Estrogen and progesterone receptors in the endometrium. Ann. N. Y. Acad. Sci., 816: 99-115, 1997.
12. Mote, P. A., Balleine, R. L., McGowan, E. M., and Clarke, C. L. Heterogeneity of progesterone receptors A and B expression in human endometrial glands and stroma. Hum. Reprod., 15 (Suppl. 3): 48-56, 2000.
13. Kumar, N. S., Richer, J., Owen, G., Litman, E., Horwitz, K. B., and Leslie, K. K. Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometdal cancer cells: implications for unopposed estrogen action. Cancer Res., 58: 1860-1865, 1998.
14. Sakamoto, H., Kinoshita, K., Nakayama, Y., Takami, T., Ohtani, K., Izuka, S., and Satoh, K. Gene expression in primary, metastatic and recurrent lesions of endometrial cancer. Gynecol. Obstet. Investig., 48: 215-220, 1999.
15. Fukuda, K., Mori, M., Uchiyama, M., Iwai, K., Iwasaka, T., and Sugimori, H. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma. Gynecol. Oncol., 69: 220-225, 1998.
16. Fujimoto, J., Sakaguchi, H., Aoki, I., Khatun, S., Toyoki, H., and Tamaya, T. Steroid receptors and metastatic potential in endometrial cancers. J. Steroid Biochem. Mol. Biol., 75: 209-212, 2000.
17. Fujimoto, J., Ichigo, S., Hori, M., Nishigaki, M., and Tamaya, T. Expression of progesterone receptor form A and B mRNAs in gynecologic malignant tumors. Tumour Biol., 16: 254-260, 1995.
18. Fujimoto, J., Ichigo, S., Hirose, R., Sakaguchi, H., and Tamaya, T. Clinical implication of expression of progesterone receptor form A and B mRNAs in secondary spreading of gynecologic cancers. J. Steroid Biochem. Mol. Biol., 62: 449-454, 1997.
19. Arnett-Mansfield, R. L., deFazio, A., Wain, G. V., Jaworski, R. C., Byth, K., Mote, P. A., and Clarke, C. L. Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium. Cancer Res., 61: 4576-4582, 2001.
20. Sasaki, M., Dharia, A., Oh, B. R., Tanaka, Y., Fujimoto, S., and Dahiya, R. Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer. Cancer Res., 61: 97-102, 2001.
21. Misao, R., Nakanishi, Y., Sun, W., Iwagaki, S., Fujimoto, J., and Tamaya, T. Identification of exon-deleted progesterone receptor mRNAs in human uterine endometrial cancers. Oncology, 58: 60-65, 2000.
22. Auffray, C., and Rougeon, F. Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur. J. Biochem., 107: 303-314, 1980.
23. Creasman, W. T., Odicino, F., Maisonneuve, P., Beller, U., Benedet, J. L., Heintz, A. P., Ngan, H. Y., Sideri, M., and Pecorelli, S. Carcinoma of the corpus uteri. J. Epidemiol. Biostat., 6: 47-86, 2001.
24. Beavon, I. R. The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation. Eur. J. Cancer, 36: 1607-1620, 2000.
25. Leblanc, M., Poncelet, C., Soriano, D., Walker-Combrouze, F., Madelenat, P., Scoazec, J. Y., and Darai, E. Alteration of CD44 and cadherins expression: possible association with augmented aggressiveness and invasiveness of endometrial carcinoma. Virchows Arch., 438: 78-85, 2001.
26. Woodhouse, E. C., Chuaqui, R. F., and Liotta, L. A. General mechanisms of metastasis. Cancer (Phila.), 80: 1529-1537, 1997.
27. Cavallaro, U., and Christofori, G. Cell adhesion in tumor invasion and metastasis: loss of the glue is not enough. Biochim. Biophys. Acta, 1552: 39-45, 2001.
28. Rabbani, S. A., and Xing, R. H. Role of urokinase (uPA) and its receptor (uPAR) in invasion and metastasis of hormone-dependent malignancies. Int. J. Oncol., 12: 911-920, 1998.
29. Miyamori, H., Takino, T., Kobayashi, Y., Tokai, H., Itoh, Y., Seiki, M., and Sato, H. Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases. J. Biol. Chem., 276: 28204-28211, 2001.
30. Babic, A. M., Kireeva, M. L., Kolesnikova, T. V., and Lau, L. F. CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc. Natl. Acad. Sci. USA, 95: 6355-6360, 1998.
31. Underhill, C. CD44: the hyaluronan receptor. J. Cell. Sci., 103 (Pt 2): 293-298, 1992.
32. Herrlich, P., Morrison, H., Sleeman, J., Orian-Rousseau, V., Konig, H., Weg-Remers, S., and Ponta, H. CD44 acts both as a growth- and invasiveness-promoting molecule and as a tumor-suppressing cofactor. Ann. N. Y. Acad. Sci., 910: 106-118; discussion 118-120, 2000.
33. Yu, W. H., Woessner, J. F., Jr., McNeish, J. D., and Stamenkovic, I. CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes. Dev., 16: 307-323, 2002.
34. Henke, C. A., Roongta, U., Mickelson, D. J., Knutson, J. R., and McCarthy, J. B. CD44-related chondroitin sulfate proteoglycan, a cell surface receptor implicated with tumor cell invasion, mediates endothelial cell migration on fibrinogen and invasion into a fibrin matrix. J. Clin. Investig., 97: 2541-2552, 1996.
35. Denholm, E. M., Lin, Y. Q., and Silver, P. J. Anti-tumor activities of chondroitinase AC and chondroitinase B: inhibition of angiogenesis, proliferation and invasion. Eur. Pharmacol., 416: 213-221, 2001.
36. Hanamura, N., Yoshida, T., Matsumoto, E., Kawarada, Y., and Sakakura, T. Expression of fibronectin and tenascin-C mRNA by myofibroblasts, vascular cells and epithelial cells in human colon adenomas and carcinomas. Int. J. Cancer, 73: 10-15, 1997.
37. Jones, F. S., and Jones, P. L. The tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling. Dev. Dyn., 218: 235-259, 2000.
38. Jones, P. L., and Jones, F. S. Tenascin-C in development and disease: gene regulation and cell function. Matrix Biol., 19: 581-596, 2000.
39. Jahkola, T., Toivonen, T., von Smitten, K., Blomqvist, C., and Virtanen, I. Expression of tenascin in invasion border of early breast cancer correlates with higher risk of distant metastasis. Int. J. Cancer, 69: 445-447, 1996.
40. Ishihara, A., Yoshida, T., Tamaki, H., and Sakakura, T. Tenascin expression in cancer cells and stroma of human breast cancer and its prognostic significance. Clin. Cancer Res., 1: 1035-1041, 1995.
41. Romberger, D. J. Fibronectin. Int. J. Biochem. Cell. Biol., 29: 939-943, 1997.
42. Danen, E. H., and Yamada, K. M. Fibronectin, integrins, and growth control. J. Cell. Physiol., 189: 1-13, 2001.
43. Sechler, J. L., Corbett, S. A., Wenk, M. B., and Schwarzbauer, J. E. Modulation of cell-extracellular matrix interactions. Ann. N. Y. Acad. Sci., 857: 143-154, 1998.
44. Dai, D., Wolf, D. M., Litman, E. S., White, M. J., and Leslie, K. K. Progesterone inhibits human endometrial cancer cell growth and invasiveness: down-regulation of cellular adhesion molecules through progesterone B receptors. Cancer Res., 62: 881-886, 2002.
45. Giancotti, F. G., and Ruoslahti, E. Integrin signaling. Science (Wash. DC), 285: 1028-1032, 1999.
46. Ossowski, L., and Aguirre-Ghiso, J. A. Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth. Curr. Opin. Cell Biol., 12: 613-620, 2000.
47. Ruoslahti, E. Fibronectin and its α 5 β 1 integrin receptor in malignancy. Invasion Metastasis, 14: 87-97, 1994.
48. Yasuda, M., Tanaka, Y., Tamura, M., Fujii, K., Sugaya, M., So, T., Takenoyama, M., and Yasumoto, K. Stimulation of β1 integrin down-regulates ICAM-1 expression and ICAM-1-dependent adhesion of lung cancer cells through focal adhesion kinase. Cancer Res., 61: 2022-2030, 2001.
49. Brakebusch, C., Wennerberg, K., Krell, H. W., Weidle, U. H., Sallmyr, A., Johansson, S., and Fassler, R. β1 integrin promotes but is not essential for metastasis of ras-myc transformed fibroblasts. Oncogene, 18: 3852-3861, 1999.
50. Huttenlocher, A., Lakonishok, M., Kinder, M., Wu, S., Truong, T., Knudsen, K. A., and Horwitz, A. F. Integrin and cadherin synergy regulates contact inhibition of migration and motile activity. J. Cell. Biol., 141: 515-526, 1998.
51. Celetti, A., Garbi, C., Consales, C., Cerrato, A., Greco, D., Mele, E., Nitsch, L., and Grieco, M. Analysis of cadherin/catenin complexes in transformed thyroid epithelial cells: modulation by β 1 integrin subunit. Eur. J. Cell Biol., 79: 583-593, 2000.
52. Behrens, J. Cadherins and catenins: role in signal transduction and tumor progression. Cancer Metastasis Rev., 18: 15-30, 1999.